Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 695 JPY -0.74% Market Closed
Market Cap: 135.2B JPY

Operating Margin
Torii Pharmaceutical Co Ltd

11.3%
Current
10%
Average
7.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.3%
=
Operating Profit
6.8B
/
Revenue
60.4B

Operating Margin Across Competitors

Torii Pharmaceutical Co Ltd
Glance View

Market Cap
132B JPY
Industry
Pharmaceuticals

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Intrinsic Value
4 736.45 JPY
Undervaluation 1%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
11.3%
=
Operating Profit
6.8B
/
Revenue
60.4B
What is the Operating Margin of Torii Pharmaceutical Co Ltd?

Based on Torii Pharmaceutical Co Ltd's most recent financial statements, the company has Operating Margin of 11.3%.

Back to Top